On Nov. 3, 2020, OraSure Technologies announced its DNA Genotek subsidiary has received Emergency Use Authorization from the…
On Nov. 2, 2020, Novavax announced the expansion of its Maryland campus to accommodate the company’s rapid growth…
On Nov. 2, 2020, Pacific Northwest National Laboratory (PNNL) announced that in the Spring of 2020, as news…
On Nov. 1, 2020, the U.S. Department of Defense announced the start of rapid, on-site COVID-19 testing for…
On Nov. 1, 2020, scientists announced that increasing evidence shows that both natural and synthetic antimicrobial peptides (AMPs),…
On Oct. 30, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced enrollment of volunteers in a phase…
On Oct. 30, 2020, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of…
On Oct. 29, 2020, Mammoth Biosciences announced that it had signed agreements with MilliporeSigma and Hamilton Company targeting…
On Oct. 29, 2020, AquaBounty Technologies announced that it had identified Mayfield, Kentucky as the potential location for…
On Oct. 29, 2020, Takeda Pharmaceutical announced that it would import and distribute 50 million doses of Moderna’s…
On Oct. 29, 2020, UC Berkeley announced that it had launched a new high-throughput pop-up lab – a…
On Oct. 28, 2020, Eli Lilly announced an initial agreement with the U.S. government to supply 300,000 vials…
On Oct. 28, 2020, University of Texas (UT) Southwestern scientists reported that an X-ray test commonly used to…
On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…
On Oct. 27, 2020, a National Institutes of Health (NIH) study of 5,000 women found that approximately 1…
On Oct. 27, 2020, researchers from the National Institutes of Health (NIH) announced they had discovered a new…
On Oct. 27, 2020, Moderna announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United…
On Oct. 27, 2020, Novavax announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19…
On Oct. 26, 2020, BioSig Technologies and its majority owned subsidiary, ViralClear Pharmaceuticals, announced the halting of its…
On Oct. 26, 2020, Moderna announced a supply agreement with the Ministry of Public Health of Qatar for…
On Oct. 26, 2020, PerkinElmer announced that its PKamp Respiratory SARS-CoV-2 RT-PCR Panel had received clearance to be…
On Oct. 26, 2020, Todos Medical announced the completion of the instrument validation in its mobile lab division….
On Oct. 26, 2020, Todos Medical announced the completion of clinical validation and CLIA certification for MOTO+PARA’s mobile…
On Oct. 23, 2020, NIH researchers reported that the plant compound apigenin improved the cognitive and memory deficits…
On Oct. 22, 2020, Oxford Immunotec announced that it had been selected to provide T cell testing to…
On Oct. 22, 2020, Moderna announced that it had completed enrollment of 30,000 participants for the Phase 3…
On Oct. 22, 2020, Gilead Sciences announced that the FDA had approved the antiviral drug Veklury (remdesivir) for…
On Oct. 21, 2020, ViiV Healthcare, majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced…
On Oct. 21, 2020, CerTest Biotec, along with BD (Becton, Dickinson), announced that the VIASURE SARS-CoV-2 (N1 +…
On Oct. 20, 2020, the U.S. Department of Defense announced an $87 million, seven-year award to the BioIndustrial…